Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, this is to inform you that Mr. Manoj Lodha has resigned as the Chief Financial Officer of the Company with effect from 5/Aug/2025.
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Filed with BSE ·
On 6ix: 6ix.com/news/announcement-under-regulation-30-lodr-resignation-of-chief-financial-officer-cfo-97
6ix hasn’t read this filing yet.
View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Updates on Acquisition
- Sudarshan Pharma Industries Ltd Press Release Jul 25 2025
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Proceedings Of Annual General Meeting Held On 25Th July 2025
Later from Sudarshan Pharma Industries
- Proceedings Of Extraordinary General Meeting Held On Monday, 11Th August 2025
- Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Thursday, 14Th August, 2025
- Sudarshan Pharma Industries Ltd Press Release Aug 11 2025
- Shareholder Meeting / Postal Ballot-Outcome of EGM
- Sudarshan Pharma Industries Ltd Press Release Aug 12 2025
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries